Characterisation of the novel SCN5A-P1891A variant, implicated in left ventricular noncompaction cardiomyopathy in a Finnish family, using human induced pluripotent stem cell-derived cardiomyocytes.

1 September 2024 (16:00 - 16:50)
Organised by: Logo
Congress Presentation Part of: Novel insights into arrhythmias Cardiomyopathies ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by